Showing results (461-470 of 1,523) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|June 3, 2017
Implications for Drug Characterization in Glucose Tolerance Tests Without Insulin: Simulation Study of Power and Predictions Using Model-Based AnalysisS M Sheikh Ghadzi, M O Karlsson, M C Kjellsson
CPT: Pharmacometrics & Systems Pharmacology|May 16, 2018
Benchmarking QSP Models Against Simple Models: A Path to Improved Comprehension and Predictive PerformanceAndrew M Stein, Michael Looby
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2016
Pembrolizumab: Role of Modeling and Simulation in Bringing a Novel Immunotherapy to Patients With MelanomaR de Greef, J Elassaiss-Schaap, M Chatterjee, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 26, 2017
Time-to-Event Analysis of Polatuzumab Vedotin-Induced Peripheral Neuropathy to Assist in the Comparison of Clinical Dosing RegimensD Lu, W R Gillespie, S Girish, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 27, 2017
A quantitative systems physiology model of renal function and blood pressure regulation: Model descriptionK M Hallow, Y Gebremichael
CPT: Pharmacometrics & Systems Pharmacology|April 28, 2018
Improving Interpretation of New and Old Serum Biomarkers of Drug-Induced Liver Injury Through Mechanistic ModelingPaul B Watkins
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2013
PKPD Modeling of Predictors for Adverse Effects and Overall Survival in Sunitinib-Treated Patients With GISTE K Hansson, G Ma, M A Amantea, et al.
CPT: Pharmacometrics & Systems Pharmacology|January 8, 2017
The Impact of Mathematical Modeling in Understanding the Mechanisms Underlying Neurodegeneration: Evolving Dimensions and Future DirectionsA Lloret-Villas, T M Varusai, N Juty, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 11, 2014
Powers of the likelihood ratio test and the correlation test using empirical bayes estimates for various shrinkages in population pharmacokineticsF P Combes, S Retout, N Frey, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 22, 2013
PKPD Modeling of VEGF, sVEGFR-2, sVEGFR-3, and sKIT as Predictors of Tumor Dynamics and Overall Survival Following Sunitinib Treatment in GISTE K Hansson, M A Amantea, P Westwood, et al.
Pageof 153